FitLife Brands (FTLF) Competitors $31.80 +0.15 (+0.47%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends FTLF vs. CRMD, VECT, NGNE, QTTB, SLRN, AVXL, NUVB, CRVS, KZR, and ALMSShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include CorMedix (CRMD), VectivBio (VECT), Neurogene (NGNE), Q32 Bio (QTTB), Acelyrin (SLRN), Anavex Life Sciences (AVXL), Nuvation Bio (NUVB), Corvus Pharmaceuticals (CRVS), Kezar Life Sciences (KZR), and Alumis (ALMS). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. CorMedix VectivBio Neurogene Q32 Bio Acelyrin Anavex Life Sciences Nuvation Bio Corvus Pharmaceuticals Kezar Life Sciences Alumis FitLife Brands (NASDAQ:FTLF) and CorMedix (NASDAQ:CRMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership. Do institutionals & insiders believe in FTLF or CRMD? 2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 34.2% of CorMedix shares are held by institutional investors. 61.3% of FitLife Brands shares are held by company insiders. Comparatively, 5.2% of CorMedix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, FTLF or CRMD? FitLife Brands has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, CorMedix has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Does the media prefer FTLF or CRMD? In the previous week, CorMedix had 22 more articles in the media than FitLife Brands. MarketBeat recorded 22 mentions for CorMedix and 0 mentions for FitLife Brands. CorMedix's average media sentiment score of 0.55 beat FitLife Brands' score of -1.00 indicating that CorMedix is being referred to more favorably in the news media. Company Overall Sentiment FitLife Brands Negative CorMedix Positive Do analysts rate FTLF or CRMD? FitLife Brands currently has a consensus price target of $40.00, suggesting a potential upside of 25.79%. CorMedix has a consensus price target of $15.20, suggesting a potential upside of 52.15%. Given CorMedix's higher possible upside, analysts plainly believe CorMedix is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50CorMedix 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings & valuation, FTLF or CRMD? FitLife Brands has higher revenue and earnings than CorMedix. CorMedix is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFitLife Brands$60.68M2.41$5.30M$1.6119.75CorMedix$60K9,617.04-$46.34M-$0.81-12.33 Is FTLF or CRMD more profitable? FitLife Brands has a net margin of 13.12% compared to CorMedix's net margin of 0.00%. FitLife Brands' return on equity of 28.06% beat CorMedix's return on equity.Company Net Margins Return on Equity Return on Assets FitLife Brands13.12% 28.06% 15.02% CorMedix N/A -79.41%-66.62% Does the MarketBeat Community favor FTLF or CRMD? CorMedix received 20 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 75.86% of users gave CorMedix an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote. CompanyUnderperformOutperformFitLife BrandsOutperform Votes250.00% Underperform Votes250.00% CorMedixOutperform Votes2275.86% Underperform Votes724.14% SummaryFitLife Brands beats CorMedix on 10 of the 19 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$146.22M$1.32B$5.40B$8.53BDividend YieldN/AN/A5.13%4.14%P/E Ratio19.757.65115.5615.18Price / Sales2.418.081,484.3492.77Price / Cash19.7615.7539.6634.07Price / Book5.232.094.665.02Net Income$5.30M-$52.95M$119.06M$225.46M7 Day Performance0.28%-0.37%0.80%0.37%1 Month Performance-2.30%6.66%5.65%3.57%1 Year Performance42.47%11.97%36.76%29.44% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands3.906 of 5 stars$31.80+0.5%$40.00+25.8%+44.0%$146.22M$60.68M19.7520Negative NewsCRMDCorMedix2.7105 of 5 stars$10.06flat$15.20+51.2%+193.8%$580.79M$806,119.00-10.8130Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeVECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030NGNENeurogene1.7795 of 5 stars$44.01+0.6%$51.00+15.9%N/A$571.87M$925,000.000.0090QTTBQ32 Bio1.9454 of 5 stars$47.23+2.0%$72.33+53.2%N/A$569.59M$-6,651,000.00-2.0539News CoverageSLRNAcelyrin3.1337 of 5 stars$5.68-3.7%$11.17+96.6%-38.4%$562.47MN/A-2.00135Upcoming EarningsAVXLAnavex Life Sciences3.4845 of 5 stars$6.62+15.9%$40.00+504.2%+21.6%$560.33MN/A-13.2440News CoverageGap UpHigh Trading VolumeNUVBNuvation Bio3.8174 of 5 stars$2.22-5.1%$6.40+188.9%+98.3%$552.08M$1.44M-1.0560Upcoming EarningsCRVSCorvus Pharmaceuticals1.5974 of 5 stars$8.84+0.5%$10.83+22.5%+671.2%$550.45MN/A-19.6430Upcoming EarningsAnalyst DowngradeShort Interest ↑KZRKezar Life Sciences4.0456 of 5 stars$7.45-9.0%$45.00+504.0%-5.2%$542.37M$7M-5.4860Stock SplitHigh Trading VolumeALMSAlumisN/A$11.32+0.8%$27.50+142.9%N/A$534.51MN/A0.00N/AAnalyst ForecastNews Coverage Related Companies and Tools Related Companies CorMedix Competitors VectivBio Competitors Neurogene Competitors Q32 Bio Competitors Acelyrin Competitors Anavex Life Sciences Competitors Nuvation Bio Competitors Corvus Pharmaceuticals Competitors Kezar Life Sciences Competitors Alumis Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FTLF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
